ATE234109T1 - Cetp zur erhöhung des hdl-cholesterol-gehalts - Google Patents

Cetp zur erhöhung des hdl-cholesterol-gehalts

Info

Publication number: ATE234109T1
Authority: AT; Austria
Prior art keywords: cetp; hdl cholesterol; cholesterol content; increase hdl; stimulating
Prior art date: 1995-06-06

Application number

AT96918201T

Other languages

English (en)

Inventor

Deborah Y Kwoh

Steven W Brostoff

Dennis J Carlo

Original Assignee

Avant Immunotherapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-06

Filing date

1996-06-05

Publication date

2003-03-15

1996-06-05 Application filed by Avant Immunotherapeutics Inc filed Critical Avant Immunotherapeutics Inc

2003-03-15 Application granted granted Critical

2003-03-15 Publication of ATE234109T1 publication Critical patent/ATE234109T1/de

Links

KEWSCDNULKOKTG-UHFFFAOYSA-N 4-cyano-4-ethylsulfanylcarbothioylsulfanylpentanoic acid Chemical compound CCSC(=S)SC(C)(C#N)CCC(O)=O KEWSCDNULKOKTG-UHFFFAOYSA-N 0.000 title abstract 5
102100037637 Cholesteryl ester transfer protein Human genes 0.000 title abstract 5
101000880514 Homo sapiens Cholesteryl ester transfer protein Proteins 0.000 title abstract 5
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
235000012000 cholesterol Nutrition 0.000 title abstract 2
230000028993 immune response Effects 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
230000004936 stimulating effect Effects 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
108010058846 Ovalbumin Proteins 0.000 abstract 1
239000002671 adjuvant Substances 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1
229940092253 ovalbumin Drugs 0.000 abstract 1
230000004044 response Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Ink Jet Recording Methods And Recording Media Thereof (AREA)
Color Television Image Signal Generators (AREA)
Materials For Photolithography (AREA)

AT96918201T 1995-06-06 1996-06-05 Cetp zur erhöhung des hdl-cholesterol-gehalts ATE234109T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US48245495A	1995-06-06	1995-06-06
PCT/US1996/009143 WO1996039168A1 (en)	1995-06-06	1996-06-05	Method for increasing hdl cholesterol level

Publications (1)

Publication Number	Publication Date
ATE234109T1 true ATE234109T1 (de)	2003-03-15

Family

ID=23916145

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96918201T ATE234109T1 (de)	1995-06-06	1996-06-05	Cetp zur erhöhung des hdl-cholesterol-gehalts

Country Status (9)

Country	Link
US (1)	US7074407B1 (de)
EP (1)	EP0831881B1 (de)
JP (1)	JP3910635B2 (de)
AT (1)	ATE234109T1 (de)
CA (1)	CA2223177A1 (de)
DE (1)	DE69626642T2 (de)
DK (1)	DK0831881T3 (de)
ES (1)	ES2190470T3 (de)
WO (1)	WO1996039168A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6410022B1 (en)	1995-05-01	2002-06-25	Avant Immunotherapeutics, Inc.	Modulation of cholesteryl ester transfer protein (CETP) activity
JP3910635B2 (ja)	1995-06-06	2007-04-25	アバントイミュノーセラピューティクス，インコーポレイテッド	Ｈｄｌコレステロールレベルを増大する方法
US6284533B1 (en)	1996-05-01	2001-09-04	Avant Immunotherapeutics, Inc.	Plasmid-based vaccine for treating atherosclerosis
US6846808B1 (en)	1996-05-01	2005-01-25	Avant Immunotherapeutics, Inc.	Plasmid-based vaccine for treating atherosclerosis
CA2307012A1 (en) *	1997-10-20	1999-04-29	Avant Immunotherapeutics, Inc.	Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
US6300308B1 (en) *	1997-12-31	2001-10-09	Board Of Regents, The University Of Texas System	Methods and compositions for inducing autoimmunity in the treatment of cancers
WO2002032935A1 (es) *	1999-12-13	2002-04-25	Universidad Nacional Autonoma De Mexico	Metodo inmunoenzimatico para cuantificar
MX347400B (es) *	2012-06-29	2017-04-18	Univ Nac Autónoma De México	Vacuna de aplicacion nasal contra el desarrollo de la enfermedad aterosclerotica y el higado graso.
CN105859837B (zh)	2014-10-22	2020-11-20	台北医学大学	胆固醇酯转运蛋白抗原肽和融合蛋白以及其组合物和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6143305A (en)	1973-05-07	2000-11-07	The Ohio State University	Antigenically modified polypeptides composition
US5126399A (en)	1986-04-30	1992-06-30	Board Of Regents, The University Of Texas System	Methods and compositions for the preparation and use of site-directed immunologic reagents
US5338829A (en)	1988-04-20	1994-08-16	Trustees Of The University Of Pennsylvania	Peptides derived from human immunodeficiency virus-1 GP160
GB8812214D0 (en)	1988-05-24	1988-06-29	Hoffmann La Roche	Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
US5242687A (en)	1989-03-15	1993-09-07	Tkb Associates Limited Partnership	Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells
US5264341A (en) *	1989-08-30	1993-11-23	Eli Lilly And Company	Selective cloning for high monoclonal antibody secreting hybridomas
AU666473B2 (en)	1990-12-10	1996-02-15	Entremed, Inc	A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
EP0618803A4 (de) *	1991-12-19	1995-03-22	Southwest Found Biomed Res	Polypeptide als inhibitoren gegen cholesterylester-transferase, antikörper gegen die synthetischen polypeptide und prophylaktische und therapeutische behandlungsweisen der atherosklerose.
AU4377793A (en)	1992-05-20	1993-12-13	Johns Hopkins University, The	Alternative receptor therapy
US5279540A (en)	1992-09-24	1994-01-18	Davidson Michael H	Method for reducing the risk of atherosclerosis
US5618683A (en)	1993-04-13	1997-04-08	Brocia; Robert W.	Diagnostic kit for cholesteryl ester transfer protein (CETP) activity measurement and a new synthetic particle used therein
US5759551A (en)	1993-04-27	1998-06-02	United Biomedical, Inc.	Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
ES2180576T3 (es)	1993-04-27	2003-02-16	United Biomedical Inc	Construcciones peptidicas de lhrh inmunogenicas y estimuladores de inmunidad universales sinteticos para vacunas.
KR950703580A (ko) *	1993-08-04	1995-09-20	프랭크 에프. 레드포드, 쥬니어	CETP 억제 폴리펩티드, 그 합성 폴리펩티드에 대한 항체 및 아테롬성 동맥경화증의 예방학적 및 치료학적 처치(CETP Inhibitor Polypeptide, Antibodies against the Synthetic Polypeptide and Prophylactic and Therapeutic AntiAtheroselerosis Treatments)
DK96493D0 (da)	1993-08-26	1993-08-26	Mouritsen Og Elsner Aps	Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
EP0733061A1 (de)	1994-11-12	1996-09-25	LG Chemical Limited	Peptidinhibitoren des Cholesterylesther - Transferprotein und prophylaktische und therapeutische anti - artheriosklerose Agenten
US5705388A (en)	1994-12-23	1998-01-06	Ribozyme Pharmaceuticals, Inc.	CETP Ribozymes
US6410022B1 (en)	1995-05-01	2002-06-25	Avant Immunotherapeutics, Inc.	Modulation of cholesteryl ester transfer protein (CETP) activity
JP3910635B2 (ja)	1995-06-06	2007-04-25	アバントイミュノーセラピューティクス，インコーポレイテッド	Ｈｄｌコレステロールレベルを増大する方法
US6284533B1 (en)	1996-05-01	2001-09-04	Avant Immunotherapeutics, Inc.	Plasmid-based vaccine for treating atherosclerosis
CA2250428A1 (en)	1996-05-01	1997-11-06	T Cell Sciences, Inc.	Plasmid-based vaccine for treating atherosclerosis
US5994310A (en)	1998-09-03	1999-11-30	Bayer Corporation	Peptide ligands for affinity purification of human Factor VIII

1996
- 1996-06-05 JP JP50153397A patent/JP3910635B2/ja not_active Expired - Fee Related
- 1996-06-05 WO PCT/US1996/009143 patent/WO1996039168A1/en not_active Ceased
- 1996-06-05 DK DK96918201T patent/DK0831881T3/da active
- 1996-06-05 ES ES96918201T patent/ES2190470T3/es not_active Expired - Lifetime
- 1996-06-05 AT AT96918201T patent/ATE234109T1/de not_active IP Right Cessation
- 1996-06-05 DE DE69626642T patent/DE69626642T2/de not_active Expired - Fee Related
- 1996-06-05 CA CA002223177A patent/CA2223177A1/en not_active Abandoned
- 1996-06-05 EP EP96918201A patent/EP0831881B1/de not_active Expired - Lifetime
2000
- 2000-03-10 US US09/523,033 patent/US7074407B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPH11507910A (ja)	1999-07-13
AU6091296A (en)	1996-12-24
ES2190470T3 (es)	2003-08-01
US7074407B1 (en)	2006-07-11
EP0831881B1 (de)	2003-03-12
DE69626642T2 (de)	2004-01-29
JP3910635B2 (ja)	2007-04-25
DE69626642D1 (de)	2003-04-17
DK0831881T3 (da)	2003-07-07
CA2223177A1 (en)	1996-12-12
EP0831881A1 (de)	1998-04-01
WO1996039168A1 (en)	1996-12-12
AU715410B2 (en)	2000-02-03

Legal Events

Date

Code

Title

Description

2003-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0831881

Country of ref document: EP

2008-03-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
NZ314058A (en)	2000-08-25	Use of ganglioside-KLH conjugate vaccines with QS-21 to treat cancer
ATE165515T1 (de)	1998-05-15	Immuntoleranzinduzierendes agens
MXPA02005576A (es)	2002-12-13	Vacuna para la prevencion y tratamiento de la enfermedad de alzheimer y otras enfermedades relacionadas con amiloides.
IL125590A (en)	2001-08-26	Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
BR0012424A (pt)	2002-07-02	Peptìdeos meningocócicos antigênicos
EP0866133A3 (de)	2001-09-26	Einer Gruppe B Streptococcus Impfstoff
DE69738138D1 (de)	2007-10-25	Induktion von immunologischer Toleranz gegen einen therapeutischen Antikörper durch Varianten des therapeutischen Antikörpers
OA09802A (en)	1994-04-15	Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus.
EP0090581A3 (de)	1984-10-24	Kleine, für Maul- und Klauenseuche spezifische Peptide
DE69626642D1 (de)	2003-04-17	Cetp zur erhöhung des hdl-cholesterol-gehalts
DE69333448D1 (en)	2004-04-15	P53 impfstoff
NZ312502A (en)	1999-03-29	Clostridium difficile toxins as mucosal adjuvants
BR0312808A (pt)	2005-04-19	Proteìna de fusão igg fc/hiv-gp120/c3d
IL98655A0 (en)	1992-07-15	Improved adjuvants and vaccines
WO2003000719A8 (en)	2004-02-19	Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same
GB9406492D0 (en)	1994-05-25	Malaria peptides
GB9014950D0 (en)	1990-08-29	Ehv-4 glycoprotein vaccine
EP0955366A4 (de)	2002-08-14	Antigenes protein aus malassezia
HU9301797D0 (en)	1993-10-28	Utilization of il-4 for producing pharmaceutical preparatives improving immunoreaction
AU7196098A (en)	1998-08-13	Induction of protection against viral infection
GB9818133D0 (en)	1998-10-14	Vaccine
GR3018529T3 (en)	1996-03-31	Nematode vaccine.
WO2002004497A3 (en)	2002-08-01	Multiple antigenic peptides immunogenic against streptococcus pneumoniae
WO2000018429A3 (en)	2000-07-06	Vaccine based on attenuated $i(haemophilus somnus)
KR970074790A (ko)	1997-12-10	합성 펩티드를 함유하는 녹농균 백신 및 이것으로부터 생산된 치료제